Quarterly report pursuant to Section 13 or 15(d)

Schedule of Dilutive Effect of Various Potential Common Shares (Details)

v3.22.1
Schedule of Dilutive Effect of Various Potential Common Shares (Details) - shares
 2 Months Ended 3 Months Ended
May 20, 2022
Mar. 31, 2022
Mar. 31, 2021
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock   8,485,007,886 2,573
Warrant [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock   5,002,174,096 1,383
Convertible Preferred Stock [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock   3,093,872,894 1,087
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 467,303,282,159    
Subsequent Event [Member] | Shares Of Common Stock Outstanding [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 1,229,322,256    
Subsequent Event [Member] | Equity Option [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 26    
Subsequent Event [Member] | Warrant [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 255,666,675,553    
Subsequent Event [Member] | Convertible Debt [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 14,443,166,667    
Subsequent Event [Member] | Convertible Preferred Stock [Member]      
Subsequent Event [Line Items]      
Total dilutive potential shares of common stock, including outstanding common stock 195,964,117,657